What is the recommended dose and administration protocol for Levetiracetam (Keppra) in a 10 kg boy with convulsions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Levetiracetam Administration for Convulsions in a 10 kg Pediatric Patient

Recommended Dosing Protocol

For a 10 kg child with convulsions, administer levetiracetam 300 mg (3 ml of 100 mg/ml solution) IV over 5 minutes as a loading dose, which equals 30 mg/kg. 1

Detailed Dilution and Administration

Loading Dose Calculation

  • Weight-based dose: 30 mg/kg × 10 kg = 300 mg 1
  • Volume required: 3 ml (from 100 mg/ml concentration)
  • Dilution: Mix 3 ml levetiracetam with 17-47 ml normal saline (NS) to create a total volume of 20-50 ml 1
  • Administration rate: Infuse over 5 minutes via IV push or short infusion 1, 2

Alternative Higher Dose Option

  • For refractory status epilepticus: Consider 40 mg/kg (400 mg = 4 ml) if seizures persist after benzodiazepines 3
  • This equals 400 mg diluted in NS, administered over 5 minutes 3

Administration Method

Preparation Steps

  • Draw up 3 ml of levetiracetam (300 mg) from the vial 1
  • Add to 20-50 ml normal saline in a syringe or IV bag 1
  • No specific dilution is mandatory - levetiracetam can be given as direct IV push, but dilution improves ease of administration over 5 minutes 2

Infusion Protocol

  • Administer via secure IV access over 5 minutes 1, 2
  • Do not exceed 5-minute infusion time for optimal efficacy in acute seizures 1
  • Monitor continuously during administration 1

Maintenance Dosing After Seizure Control

Following the loading dose, continue with 150 mg (1.5 ml) IV every 12 hours for convulsive status epilepticus. 1

  • Maintenance calculation: 15 mg/kg × 10 kg = 150 mg every 12 hours 1
  • Maximum single maintenance dose: 1500 mg 1
  • For non-convulsive status epilepticus: Use same 15 mg/kg every 12 hours 1

Safety Considerations

Monitoring Requirements

  • Continuous vital sign monitoring is essential, particularly respiratory status and blood pressure 1
  • Have oxygen and airway equipment immediately available 1
  • Monitor for 30 minutes post-administration 1

Adverse Effects to Watch

  • Respiratory depression risk is minimal with levetiracetam compared to other antiepileptic drugs 1, 2
  • Hypotension occurs in only 1.7-3.2% of cases 2
  • Rare psychiatric effects: Visual and auditory hallucinations can occur, though uncommon 4
  • Higher doses (>40 mg/kg) may increase intubation risk 5

Clinical Context

Efficacy Data

  • Seizure termination rate: 68-73% for benzodiazepine-refractory status epilepticus 1
  • Pediatric studies show 83-89% seizure reduction with loading doses 2
  • No significant difference in efficacy between 20 mg/kg, 30 mg/kg, and 40 mg/kg doses 5

Pharmacokinetic Considerations in Children

  • Children require higher mg/kg doses than adults due to 30-40% higher clearance 6, 7
  • Half-life in children: 6.0 hours (shorter than adults) 6
  • Rapid absorption with peak at 0.5 hours 7
  • No dose adjustment needed for concomitant antiepileptic drugs 7

Critical Pitfalls to Avoid

  • Never delay administration for neuroimaging - treat seizures first 1
  • Do not use neuromuscular blockers alone as they only mask motor manifestations while allowing continued brain injury 1
  • Ensure IV access is secure before starting infusion to prevent extravasation 1
  • Do not skip benzodiazepines - levetiracetam is a second-line agent, not first-line 1

Treatment Algorithm Position

Levetiracetam is positioned as a second-line agent after benzodiazepines fail to control seizures 1. If seizures continue after the 300 mg loading dose, escalate to third-line agents (midazolam infusion, propofol, or pentobarbital) rather than repeating levetiracetam 1.

References

Guideline

Status Epilepticus Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Levetiracetam Loading Dose for Seizure Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Levetiracetam Dosing for Status Epilepticus

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hallucination: A rare complication of levetiracetam theraphy.

Northern clinics of Istanbul, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.